Life Sciences


Trusted By Pharma

Global biopharma cold-chain logistics spending is estimated to be $16.9 billion in 2020 and reach $18.6 billion in 2022
Pharmaceutical Commerce, 2018 Cold Chain Outlook

With rising demand for increasingly specialized and personalized medicines to address unmet therapeutic needs, pharmaceutical and clinical trial supply chains are growing more and more complex. Specialized providers that can securely transport biologics and other high-value drug products within the strict temperature ranges required are critical to biopharmaceutical developers working to bring these innovative therapies to market - and, ultimately, to patients.

Serving Pharma, Biotech & Healthcare

Having served the government and defense sector since 1971, Boyle applies equally rigorous standards to support Big Pharma, emerging biotechs, medical device manufacturers, healthcare distributors and government agencies in bringing innovative, high-quality products through the supply chain to patients in need. It is our honor to be entrusted with the responsibility of delivering thousands of shipments of life-saving medicines every year.

Time & Temperature Sensitive Shipments

We manage the entire process of securely transporting the following high-value, time and temperature-sensitive materials from manufacturer to distribution center and beyond:

  • Prescription (Rx) drug products
  • Over the counter (OTC) products
  • Biologic shipments
  • Vaccine shipments